Publications by authors named "Souhil Allaoua"
Article Synopsis
- The multidisciplinary clinical investigation center (CIC-P) aims to improve patient access to new drugs, enhance the reputation of French clinical research, and improve the quality of early-phase trials while focusing on rare diseases.
- Since 2017, CIC-P has adopted a quality approach, launching patient care satisfaction surveys to gather feedback, although a planned second survey was delayed by the COVID-19 pandemic.
- The center is pursuing ISO 9001:2015 certification to enhance performance and customer satisfaction by integrating quality improvement tools like PDCA, SWOT analysis, and FMEA, while continuously seeking to understand and meet the expectations of its stakeholders.
The coronavirus disease 2019 (COVID-19) pandemic indirectly resulted in missed therapeutic opportunities for many diseases. Here we focus on community-acquired respiratory viruses other than severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) [respiratory syncytial virus, parainfluenza and influenza A], and highlight the pandemics impact on clinical trials to develop novel therapies for other severe respiratory viral infections. We retrospectively reviewed inclusion rates within respiratory antiviral clinical trials in comparison with all other clinical trials in our clinical investigations center, before and during the COVID-19 pandemic.
View Article and Find Full Text PDFArticle Synopsis
- The Clinical Investigations Center of Saint-Louis Hospital (CIC-1427) specializes in early phase clinical trials and adapted rapidly during the COVID-19 pandemic to ensure patient and staff safety.
- The study aimed to maintain optimal management of patients in trials while adhering to safety protocols set by health authorities.
- New procedures included virtual consultations, remote monitoring, and home delivery of treatments, successfully allowing continued patient follow-up despite the challenges posed by the pandemic.